---
schema_version: "secwatch.filing_event.v1"
accession: "0001798749-24-000018"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2024-03-27T23:59:59+00:00"
generated_at: "2026-06-04T07:18:56.016883+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Aerovate Therapeutics furnishes corporate presentation; no material news disclosed

## Summary
- Filed under Item 7.01 as Regulation FD disclosure; presentation used for investor meetings starting March 27, 2024.
- Presentation focuses on pipeline for pulmonary arterial hypertension; no new clinical or financial data provided.
- No specific numbers, milestones, or guidance changes were included in the exhibit.

## SEC filing metadata
- accession: 0001798749-24-000018
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2024-03-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000018/0001798749-24-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000179874924000018/tmb-20240327x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001798749-24-000018
- JSON: https://secwatch.observer/filing/0001798749-24-000018.json
- Plain text: https://secwatch.observer/filing/0001798749-24-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.